Foresite Capital Management II’s Denali Therapeutics DNLI Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-250,000	Closed	-$5.44M	–	11
2018 Q3	$5.44M	Hold	250,000	–	–	2.01%	8
2018 Q2	$3.81M	Hold	250,000	–	–	1.34%	8
2018 Q1	$3.7M	Hold	250,000	–	–	1.23%	8
2017 Q4	$3.91M	Buy	+250,000	New	+$3.91M	1.37%	7